Related references
Note: Only part of the references are listed.Immunotherapy in uveal melanoma: novel strategies and opportunities for personalized treatment
Christos Masaoutis et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
The Prognostic Values of PARP-1 Expression in Uveal Melanoma
Malgorzata Gajdzis et al.
CELLS (2021)
Clinical Significance of Histone Deacetylase (HDAC)-1, -2, -4 and -6 Expression in Salivary Gland Tumors
Despoina Pouloudi et al.
DIAGNOSTICS (2021)
Definition of Biologically Distinct Groups of Conjunctival Melanomas According to Etiological Factors and Implications for Precision Medicine
Sophie Gardrat et al.
CANCERS (2021)
Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma
Zahra Souri et al.
CANCERS (2021)
Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia
Dimitrios Goutas et al.
DIAGNOSTICS (2021)
Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma-Associations with Clinical Parameters and Patient Survival
Malgorzata Gajdzis et al.
LIFE-BASEL (2020)
HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer
Xue-ting Hu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma
Zahra Souri et al.
CANCERS (2020)
Tumour Expression of Histone Deacetylases in Uveal Melanoma
Louis Levinzon et al.
OCULAR ONCOLOGY AND PATHOLOGY (2019)
The Role of Histone Deacetylase Inhibitors in Uveal Melanoma: Current Evidence
Marilita M. Moschos et al.
ANTICANCER RESEARCH (2018)
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Amila Suraweera et al.
FRONTIERS IN ONCOLOGY (2018)
Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
Jiaqi Liu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Histone deacetylase (HDAC)-1,-2,-4 and-6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival
Constantinos Giaginis et al.
BMC GASTROENTEROLOGY (2015)
Uveal melanoma: Estimating prognosis
Swathi Kaliki et al.
INDIAN JOURNAL OF OPHTHALMOLOGY (2015)
Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast
Jinwon Seo et al.
JOURNAL OF BREAST CANCER (2014)
Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions
Constantinos Giaginis et al.
TUMOR BIOLOGY (2014)
Histone deacetylase 1 and 2 in mesenchymal tumors
Marina Pacheco et al.
MODERN PATHOLOGY (2012)
CLINICAL SPECTRUM AND PROGNOSIS OF UVEAL MELANOMA BASED ON AGE AT PRESENTATION IN 8,033 CASES
Carol L. Shields et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Histone deacetylase-1 and-2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival
Stamatios Theocharis et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2011)
Uveal Melanoma: Trends in Incidence, Treatment, and Survival
Arun D. Singh et al.
OPHTHALMOLOGY (2011)
Histone Deacetylase (HDAC) 1 and 2 Expression and Chemotherapy in Gastric Cancer
Kathrin Mutze et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
HDAC expression and clinical prognosis in human malignancies
Wilko Weichert
CANCER LETTERS (2009)
Histone deacetylases: target enzymes for cancer therapy
Denis Mottet et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Paola Gallinari et al.
CELL RESEARCH (2007)
The diverse functions of histone lysine methylation
C Martin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
The Sir2 family of protein deacetylases
G Blander et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Cytoplasmic IκBα increases NF-κB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3
P Viatour et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
The bovine herpesvirus 1 immediate-early protein (bICP0) associates with histone deacetylase 1 to activate transcription
YG Zhang et al.
JOURNAL OF VIROLOGY (2001)